Learning Objectives:
- Outline the clinical presentation and pathophysiology of NMOSD
- Outline the imaging and laboratory findings in NMOSD
- Outline the new treatment options for NMOSD
- Compare Aquaporin-4 antibody (AQP4) and Myelin Oligodendrocyte Glycoprotein (MOG) antibody disease
Evaluation
Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135
Session date:
02/21/2022 - 4:00pm to 5:00pm CST
Location:
Medical Foundation Centennial Bldg, Room #1220
1685 Highland Ave
Madison, WI
53705
United States
See map: Google Maps
- 1.00 AMA PRA Category 1 Credit™
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar:
Discloser List CME Internal Report